FDA: Eczema Drugs Carry Cancer Risk (Reuters)


Reuters - Two eczema creams -- Novartis AG's
Elidel and Fujisawa Healthcare, Inc.'s
(4511.T) Protopic, must carry a strong warning of cancer risk,
the U.S. Food and Drug Administration said on Thursday.

Read more...